Advertisement

Obesity Surgery

, Volume 28, Issue 4, pp 1109–1116 | Cite as

Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet

  • Katherine J. P. Schwenger
  • Sandra E. Fischer
  • Timothy D. Jackson
  • Allan Okrainec
  • Johane P. Allard
Original Contributions

Abstract

Background

Non-alcoholic fatty liver disease (NAFLD) affects 75 to 100% of the patients undergoing bariatric surgery (BSx), with non-alcoholic steatohepatitis (NASH) being present in 24 to 98% of the patients. We do not know whether these rates were before or after a very low calorie diet (VLCD) often prescribed before laparoscopic BSx and what is the prevalence of NAFLD post-VLCD.

Purpose

The purpose of this study is to determine the prevalence of simple steatosis (SS) and NASH in obese individuals undergoing BSx post-VLCD and assess biochemical markers pre- and post-VLCD in a subgroup of patients.

Methods

One hundred and thirty-nine patients undergoing BSx at a single Canadian bariatric program had biochemical and clinical variables collected pre-VLCD. In 21 patients, biochemical measurements were repeated post-VLCD. During BSx, a wedged liver biopsy was performed in all patients and histology was reported as normal liver (NL), SS, or NASH.

Results

NAFLD was diagnosed in 76.3% of the BSx patients with 61.9% having SS and 14.4% having NASH; 23.7% had NL. Those with NASH had significantly higher (p < 0.05) pre-VLCD ALT, AST, insulin resistance, and proportion of individuals with diabetes compared to those with NL. Overall, VLCD resulted in significant decreases in BMI, ALP, fasting glucose and insulin, HbA1c, total cholesterol, HDL and LDL cholesterol, and significant increases in AST and ALT. Changes were similar between groups.

Conclusions

Post-VLCD, the prevalence of NAFLD and NASH was lower compared to published reports, with almost 25% of the patients having a NL. With VLCD, metabolic and clinical changes were similar between the three groups suggesting that pre-VLCD factors may affect liver histology.

Keywords

Non-alcoholic fatty liver disease Very low calorie diet Bariatric surgery Obesity 

Notes

Acknowledgements

The authors are appreciative and acknowledge the important contributions made by the research assistants, clinical staff, surgical staff, bariatric clinic nurses, operating room nurses, and study participants at the University Health Network.

Funding

This study was funded by the Canadian Institutes for Health Research, Operating Grant MOP-126139.

Compliance with Ethical Standards

Conflict of Interest

Authors 1–3 and 5 have no conflict of interest to declare. Author 4 has relevant financial activities outside of the submitted work. He is provided an honorarium for speaking and teaching from Ethicon and Medtronic.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Obesity in Canada: a whole-of-society approach for healthier Canada. Senate. Standing Committee on Social Affairs SaT; 2016.Google Scholar
  2. 2.
    Table 105-0501 - Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2013 boundaries) and peer groups, occasional. Statistics Canada; 2013.Google Scholar
  3. 3.
    Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Mostaedi R, Lackey DE, Adams SH, et al. Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery. Obes Surg. 2014;24(6):927–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014 Jun 11;311(22):2297–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Hewitt S, Humerfelt S, Sovik TT, et al. Long-term improvements in pulmonary function 5 years after bariatric surgery. Obes Surg. 2014;24(5):705–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.CrossRefPubMedGoogle Scholar
  8. 8.
    Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;15(2):CD003641.Google Scholar
  9. 9.
    Charrez B, Qiao L, Hebbard L. Hepatocellular carcinoma and non-alcoholic steatohepatitis: the state of play. World J Gastroenterol. 2016;22(8):2494–502.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep. 2002;2(3):210–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44–52.CrossRefPubMedGoogle Scholar
  12. 12.
    Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–95.CrossRefPubMedGoogle Scholar
  13. 13.
    Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.CrossRefPubMedGoogle Scholar
  14. 14.
    Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45(4):600–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Moschen AR, Molnar C, Wolf AM, et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol. 2009;51(4):765–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg. 2004;14(9):1165–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Doyle A, Adeyi O, Khalili K, et al. Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation. Liver Transpl. 2016;22(9):1295–300.CrossRefPubMedGoogle Scholar
  19. 19.
    Gastrointestinal surgery for severe obesity. Consensus statement / NIH Consensus Development Conference National Institutes of Health Consensus Development Conference. 1991 Mar 25-27;9(1):1-20.Google Scholar
  20. 20.
    Bastow MD. Anthropometrics revisited. Proc Nutr Soc. 1982;41(3):381–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–74.CrossRefPubMedGoogle Scholar
  23. 23.
    Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Saleh F, Doumouras AG, Gmora S, et al. Outcomes of the Ontario Bariatric Network: a cohort study. CMAJ Open. 2016;4(3):E383–E9.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Canadian Institute for Health Information. Bariatric surgery in Canada. Bariatric Surgery in Canada. Ottawa, ON: CIHI; 2014.Google Scholar
  26. 26.
    Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5–10.PubMedGoogle Scholar
  27. 27.
    Busetto L, Tregnaghi A, De Marchi F, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002;10(5):408–11.CrossRefPubMedGoogle Scholar
  28. 28.
    Nguyen NT, Longoria M, Gelfand DV, et al. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg. 2005;15(7):1077–81.CrossRefPubMedGoogle Scholar
  29. 29.
    Lewis MC, Phillips ML, Slavotinek JP, et al. Change in liver size and fat content after treatment with Optifast® very low calorie diet. Obes Surg. 2006;16(6):697–701.CrossRefPubMedGoogle Scholar
  30. 30.
    Frith J, Day CP, Henderson E, et al. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55(6):607–13.CrossRefPubMedGoogle Scholar
  31. 31.
    Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 2003;285(4):E906–16.CrossRefPubMedGoogle Scholar
  32. 32.
    Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 2000;26(2):98–106.PubMedGoogle Scholar
  33. 33.
    Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis. 2011;12(1):10–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Bugianesi E, Marchesini G, Gentilcore E, et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology. 2006;44(6):1648–55.CrossRefPubMedGoogle Scholar
  35. 35.
    Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr Diab Rep. 2015;15(6):607.CrossRefPubMedGoogle Scholar
  36. 36.
    Liu KH, Chan YL, Chan JC, et al. Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes. 2006;30(5):787–93.CrossRefGoogle Scholar
  37. 37.
    Kral JG, Schaffner F, Pierson Jr RN, et al. Body fat topography as an independent predictor of fatty liver. Metabolism. 1993;42(5):548–51.CrossRefPubMedGoogle Scholar
  38. 38.
    Stefan N, Machicao F, Staiger H, et al. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia. 2005;48(11):2282–91.CrossRefPubMedGoogle Scholar
  39. 39.
    Faith JJ, McNulty NP, Rey FE, et al. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333(6038):101–4.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105–8.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev. 2012;13(9):799–809.CrossRefPubMedGoogle Scholar
  42. 42.
    Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61(9):3202–7.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Spencer MD, Hamp TJ, Reid RW, et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011;140(3):976–86.CrossRefPubMedGoogle Scholar
  44. 44.
    Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2005;172(7):899–905.CrossRefPubMedGoogle Scholar
  45. 45.
    Wahlroos S, Phillips ML, Lewis MC, et al. Rapid significant weight loss and regional lipid deposition: implications for insulin sensitivity. Obes Res Clin Pract. 2007;1(1):1–78.CrossRefPubMedGoogle Scholar
  46. 46.
    Gasteyger C, Larsen TM, Vercruysse F, et al. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr. 2008;87(5):1141–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Hoy MK, Heshka S, Allison DB, et al. Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. Am J Clin Nutr. 1994;60(2):249–54.CrossRefPubMedGoogle Scholar
  48. 48.
    Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012 Jan;56(1):255–66.CrossRefPubMedGoogle Scholar
  49. 49.
    Andersen T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol. 1991;12(2):224–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Ghadir MR, Riahin AA, Havaspour A, et al. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon. 2010;10(4):285–8.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Selimoglu MA, Aydogdu S, Yagci RV. Lipid parameters in childhood cirrhosis and chronic liver disease. Pediatr Int. 2002;44(4):400–3.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Institute of Medical ScienceUniversity of TorontoTorontoCanada
  2. 2.Toronto General HospitalUniversity Health NetworkTorontoCanada
  3. 3.Department of Laboratory Medicine and PathobiologyUniversity of TorontoTorontoCanada
  4. 4.Division of General SurgeryUniversity of TorontoTorontoCanada
  5. 5.Division of General Surgery|University Health NetworkTorontoCanada
  6. 6.Department of MedicineUniversity of TorontoTorontoCanada
  7. 7.Department of Nutritional SciencesUniversity of TorontoTorontoCanada

Personalised recommendations